Purification and Characterization of the Human γ-Secretase Complex
γ-Secretase is a member of an unusual class of proteases with intramembrane catalytic sites. This enzyme cleaves many type I membrane proteins, including the amyloid β-protein (Aβ) precursor (APP) and the Notch receptor. Biochemical and genetic studies have identified four membrane proteins as compo...
Gespeichert in:
Veröffentlicht in: | Biochemistry (Easton) 2004-08, Vol.43 (30), p.9774-9789 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | γ-Secretase is a member of an unusual class of proteases with intramembrane catalytic sites. This enzyme cleaves many type I membrane proteins, including the amyloid β-protein (Aβ) precursor (APP) and the Notch receptor. Biochemical and genetic studies have identified four membrane proteins as components of γ-secretase: heterodimeric presenilin (PS) composed of its N- and C-terminal fragments (PS-NTF/CTF), a mature glycosylated form of nicastrin (NCT), Aph-1, and Pen-2. Recent data from studies in Drosophila, mammalian, and yeast cells suggest that PS, NCT, Aph-1, and Pen-2 are necessary and sufficient to reconstitute γ-secretase activity. However, many unresolved issues, in particular the possibility of other structural or regulatory components, would be resolved by actually purifying the enzyme. Here, we report a detailed, multistep purification procedure for active γ-secretase and an initial characterization of the purified protease. Extensive mass spectrometry of the purified proteins strongly suggests that PS-NTF/CTF, mNCT, Aph-1, and Pen-2 are the components of active γ-secretase. Using the purified γ-secretase, we describe factors that modulate the production of specific Aβ species: (1) phosphatidylcholine and sphingomyelin dramatically improve activity without changing cleavage specificity within an APP substrate; (2) increasing CHAPSO concentrations from 0.1 to 0.25% yields a ∼100% increase in Aβ42 production; (3) exposure of an APP-based recombinant substrate to 0.5% SDS modulates cleavage specificity from a disease-mimicking pattern (high Aβ42/43) to a physiological pattern (high Aβ40); and (4) sulindac sulfide directly and preferentially decreases Aβ42 cleavage within the purified complex. Taken together, our results define a procedure for purifying active γ-secretase and suggest that the lipid-mediated conformation of both enzyme and substrate regulate the production of the potentially neurotoxic Aβ42 and Aβ43 peptides. |
---|---|
ISSN: | 0006-2960 1520-4995 |
DOI: | 10.1021/bi0494976 |